Stockreport

Cytokinetics: Strong Story, But Valuation Leaves Limited Upside [Seeking Alpha]

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview
PDF oHCM peak revenue is realistically $764M–$1.72B after royalties, supporting only 40–80% of current equity value at a 4x sales multiple. nHCM represents the primary up [Read more]